SEARCH

SEARCH BY CITATION

References

  • 1
    McGovern VJ, Mihm MC Jr, Bailly C et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32:144657.
  • 2
    LeBoit PE, Burg G, Weedon D et al. Pathology and Genetics of Skin Tumours. Lyon, France: IARC Press, 2006.
  • 3
    Weedon D. Weedon's Skin Pathology, 3rd edn. London: Elsevier Publications, 2010.
  • 4
    Clark WH Jr, Mihm MC Jr. Lentigo maligna and lentigo-maligna melanoma. Am J Pathol 1969; 55:3967.
  • 5
    Weyers W, Bonczkowitz M, Weyers I et al. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol 1996; 18:5606.
  • 6
    Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994; 31:7985.
  • 7
    Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987; 116:30310.
  • 8
    Stevenson O, Ahmed I. Lentigo maligna: prognosis and treatment options. Am J Clin Dermatol 2005; 6:15164.
  • 9
    Kelly JW. Following lentigo maligna may not prevent the development of life-threatening melanoma. Arch Dermatol 1992; 128:65760.
  • 10
    Michalik EE, Fitzpatrick TB, Sober AJ. Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma. Report of two cases. Arch Dermatol 1983; 119:8315.
  • 11
    Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group: Wellington, 2008. Available at: http://www.nhmrc.gov.au/guidelines/publications/cp111 (last accessed 17 October 2013).
  • 12
    Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 2002; 47:7438.
  • 13
    Hazan C, Dusza SW, Delgado R et al. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J Am Acad Dermatol 2008; 58:1428.
  • 14
    Zitelli JA. Surgical margins for lentigo maligna, 2004. Arch Dermatol 2004; 140:6078.
  • 15
    Fogarty GB. Recent Australian advances in the radiotherapy of skin cancer. Int J Bioautomation 2012; 16:4352.
  • 16
    Sachse MM, Wagner G, Aydin H et al. Treatment of extensive lentigo maligna melanoma of the scalp by brachytherapy moulage technique. Br J Dermatol 2011; 164:21921.
  • 17
    Rupprecht R, Lippold A, Auras C et al. Late side-effects with cosmetic relevance following soft X-ray therapy of cutaneous neoplasias. J Eur Acad Dermatol Venereol 2007; 21:17885.
  • 18
    Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction I: Comparison of the effects of daily and once-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984; 10:5938.
  • 19
    Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction II: Comparison of the effects of daily and twice-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984; 10:599606.
  • 20
    Kopf AW, Bart RS, Gladstein AH. Treatment of melanotic freckle with x-rays. Arch Dermatol 1976; 112:8017.
  • 21
    Harwood AR. Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys 1983; 9:101921.
  • 22
    Campolmi P, Bonan P, Mantellassi G et al. Radiotherapy of lentigo maligna and lentigo maligna melanoma. Skin Cancer 1994; 9:236.
  • 23
    Tsang RW, Liu FF, Wells W et al. Lentigo maligna of the head and neck. Results of treatment by radiotherapy. Arch Dermatol 1994; 130:100812.
  • 24
    Christie DR, Tiver KW. Radiotherapy for melanotic freckles. Australas Radiol 1996; 40:3313.
  • 25
    Panizzon R. Radiotherapy of lentigo maligna and lentigo maligna melanoma. Skin Cancer 1999; 14:2037.
  • 26
    Schmid-Wendtner MH, Brunner B, Konz B et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol 2000; 43:47782.
  • 27
    Farshad A, Burg G, Panizzon R et al. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol 2002; 146:10426.
  • 28
    Hedblad MA, Mallbris L. Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma. J Am Acad Dermatol 2012; 67:608.
  • 29
    Dancuart F, Harwood AR, Fitzpatrick PJ. The radiotherapy of lentigo maligna and lentigo maligna melanoma of the head and neck. Cancer 1980; 45:227983.
  • 30
    Harwood AR. Melanomas of the head and neck. J Otolaryngol 1983; 12:649.
  • 31
    Harwood AR. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1982; 6:31016.
  • 32
    Harwood AR, Lawson VG. Radiation therapy for melanomas of the head and neck. Head Neck Surg 1982; 4:46874.
  • 33
    Petratos MA, Kopf AW, Bart RS et al. Treatment of melanotic freckle with x-rays. Arch Dermatol 1972; 106:18994.
  • 34
    Guitera P, Moloney FJ, Menzies SW et al. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy. JAMA Dermatol 2013; 149:17.
  • 35
    Guitera P, Pellacani G, Crotty KA et al. The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face. J Invest Dermatol 2010; 130:208091.
  • 36
    International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report 50. Bethesda, MD: ICRU, 1993.
  • 37
    Guitera P, Li LL, Scolyer RA et al. Morphologic features of melanophages under in vivo reflectance confocal microscopy. Arch Dermatol 2010; 146:4928.
  • 38
    Johansen J, Bentzen SM, Overgaard J et al. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996; 40:1019.